Le Lézard
Classified in: Science and technology
Subject: Product/Service

Keysight Introduces Pulse Generator Option for Handheld Analyzers


Keysight Technologies, Inc. (NYSE: KEYS) has expanded the software applications for its FieldFox portfolio of handheld radio frequency (RF) analyzers to include a pulse generator. Available for B- and C-Series FieldFox handheld analyzers, the downloadable Option 357 pulse generator offers field engineers a diverse array of pulse types at frequencies up to 54 GHz.

Field engineers conduct routine maintenance on and troubleshoot RF, microwave, and millimeter wave (mmWave) systems. During their work, they need to test a variety of devices and systems to ensure they are working as intended by using the data signals created by a pulse generator. To generate the diverse types of pulses needed for field testing, engineers need multiple expensive pulse generators that may not be specifically designed for field use.

The Keysight FieldFox Option 357 signal generator software addresses this challenge by enabling engineers to quickly upgrade existing B- and C-Series FieldFox handheld analyzers to meet their specific testing needs on the fly. All that is needed for field engineers to take advantage of the only handheld analyzer in the industry with an embedded pulse generator is a software license key and a firmware upgrade.

The new Option 357 signal generator application offers the following benefits:

Vince Nguyen, Vice President and General Manager, Aerospace, Defense, and Government Solution Group at Keysight, said: "When engineers are in the field, they need flexible test solutions that can be adapted quickly to rapidly changing needs. With the FieldFox Option 357 pulse generator software application, Keysight is delivering a long sought-after capability for high-impact field applications in the aerospace, automotive, and telecommunications industries. As the only handheld analyzer that features a built-in pulse generator covering up to 54 GHz, FieldFox optimizes field instrument investments with a software-defined platform that can easily be configured through software license keys."

Resources

About Keysight Technologies

At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we're delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product life cycle. We're a global innovation partner enabling customers in communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at Keysight Newsroom and www.keysight.com.


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: